The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Immune cell therapies and immune cell engineering

Original research

The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL

Online download statistics by month:

Online download statistics by month: May 2022 to March 2024

	Abstract	Full	Pdf
May 2022	781	799	232
Jun 2022	345	350	119
Jul 2022	268	268	76
Aug 2022	232	238	54
Sep 2022	213	219	75
Oct 2022	230	234	80
Nov 2022	230	233	69
Dec 2022	269	271	62
Jan 2023	223	224	72
Feb 2023	270	277	119
Mar 2023	200	201	73
Apr 2023	223	229	119
May 2023	233	238	99
Jun 2023	253	259	75
Jul 2023	202	203	55
Aug 2023	152	154	44
Sep 2023	188	189	70
Oct 2023	228	231	78
Nov 2023	221	226	67
Dec 2023	176	177	63
Jan 2024	116	118	48
Feb 2024	178	178	77
Mar 2024	189	191	117
Total	5620	5707	1943